Oxagen Ltd.
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Holding
- Established
- 1997-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.oxagen.co.uk
A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis
- First Posted Date
- 2011-10-07
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT01448902
- Locations
- π¦πΉ
Vienna Challenge Chamber, Vienna, Austria
Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects
- First Posted Date
- 2010-01-28
- Last Posted Date
- 2010-01-28
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 132
- Registration Number
- NCT01057927
- Locations
- π·πΊ
City Hospital #7, Moscow, Russian Federation
π·πΊSverdlovsk Regional Hospital #1, Ekaterinburg, Russian Federation
π·πΊResearch Institute of Pulmonology, Moscow, Russian Federation
Proof of Concept Study of OC000459 in Eosinophilic Esophagitis
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2012-01-05
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 26
- Registration Number
- NCT01056783
- Locations
- π¨π
Swiss EoE Research Group, Olten, Switzerland
OC000459 Bronchial Allergen Challenge
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2010-01-26
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT01056692
- Locations
- π¬π§
King's College London School of Medicine, London, United Kingdom
π¬π§Medicines Evaluation Unit, Manchester, United Kingdom
Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2010-09-02
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT01056575
- Locations
- π¬π§
Simbec Research Ltd, Merthyr Tydfil, United Kingdom
OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma
Phase 2
Completed
- Conditions
- Mild to Moderate Persistent Asthma
- Interventions
- Drug: OC000459 or placebo
- First Posted Date
- 2009-04-30
- Last Posted Date
- 2010-09-02
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 480
- Registration Number
- NCT00890877
- Locations
- πΊπ¦
Research site, Kiev, Ukraine
OC000459 Dose Finding Study in Hay Fever Sufferers.
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2009-02-24
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT00697281
- Locations
- π¦πΉ
Allergie Zentrum Wien West, Vienna Challenge Chamber, Vienna, Austria
Β© Copyright 2025. All Rights Reserved by MedPath